Affordable Access

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

Authors
  • Hanania, E G
  • Giles, R E
  • Kavanagh, J
  • Fu, S Q
  • Ellerson, D
  • Zu, Z
  • Wang, T
  • Su, Y
  • Kudelka, A
  • Rahman, Z
  • Holmes, F
  • Hortobagyi, G
  • Claxton, D
  • Bachier, C
  • Thall, P
  • Cheng, S
  • Hester, J
  • Ostrove, J M
  • Bird, R E
  • Chang, A
  • And 5 more
Type
Published Article
Journal
Proceedings of the National Academy of Sciences
Publisher
Proceedings of the National Academy of Sciences
Publication Date
Dec 24, 1996
Volume
93
Issue
26
Pages
15346–15351
Identifiers
PMID: 8986814
Source
Medline
License
Unknown

Abstract

To formally test the hypothesis that the granulocyte/macrophage colony-forming unit (GM-CFU) cells can contribute to early hematopoietic reconstitution immediately after transplant, the frequency of genetically modified GM-CFU after retroviral vector transduction was measured by a quantitative in situ polymerase chain reaction (PCR), which is specific for the multidrug resistance-1 (MDR-1) vector, and by a quantitative GM-CFU methylcellulose plating assay. The results of this analysis showed no difference between the transduction frequency in the products of two different transduction protocols: "suspension transduction" and "stromal growth factor transduction." However, when an analysis of the frequency of cells positive for the retroviral MDR-1 vector posttransplantation was carried out, 0 of 10 patients transplanted with cells transduced by the suspension method were positive for the vector MDR-1 posttransplant, whereas 5 of 8 patients transplanted with the cells transduced by the stromal growth factor method were positive for the MDR-1 vector transcription unit by in situ or in solution PCR assay (a difference that is significant at the P = 0.0065 level by the Fisher exact test). These data suggest that only very small subsets of the GM-CFU fraction of myeloid cells, if any, contribute to the repopulation of the hematopoietic tissues that occurs following intensive systemic therapy and transplantation of autologous hematopoietic cells.

Report this publication

Statistics

Seen <100 times